Provider records sourced from NPPES (CMS National Plan & Provider Enumeration System). Data current as of October 4, 2026.

Mr. Arvind Kumar, MD

Individual provider Hematology & Oncology Physician · NPI 1356357479

Mr. Arvind Kumar, MD practises Hematology/Oncology in Edison, New Jersey. Graduated from University Central Del Caribe Escuela De Medicina in 1985, 41 years ago. Accepts Medicare assignment and offers telehealth. Licensed in New Jersey.

Years since qualifying
41
Trained at
University Central Del Caribe Escuela De Medicina
Licensed in
NJ
In the registry since
2006
What do these letters mean?
MD — Doctor of Medicine
A physician who completed allopathic medical school.

See every abbreviation used in this directory →

Practice location Address checks out

2177 Oak Tree Rd Ste 104
Edison, NJ 08820 Not confirmed with CMS for 14 years — call before visiting
Phone: (908) 755-1165
Fax: (908) 755-2093
Show map & directions

Pin is approximate — placed at the ZIP-code centre, not the exact door.

Specialties & licences

Hematology & Oncology Physician (primary) Taxonomy 207RH0003X · Licence MA51303 (NJ)

Record details

NPI number1356357479
Entity typeIndividual (Type 1)
GenderMale
Credentials MD
Sole proprietorNo
NPI enumeratedJuly 31, 2006
Last updated in NPPESFebruary 14, 2012

Medicare enrollment

From the CMS Doctors & Clinicians file — this clinician is enrolled in Medicare.

Medicare specialtyHEMATOLOGY/ONCOLOGY
Medical schoolUNIVERSITY CENTRAL DEL CARIBE ESCUELA DE MEDICINA
Graduated 1985 (41 years in practice)
Accepts Medicare assignment Yes — accepts the Medicare-approved amount
TelehealthOffers telehealth services

Medicare patients and services, 2024

From the CMS Medicare Physician & Other Practitioners file for calendar year 2024. It counts Original Medicare patients only, so a practice that mostly sees Medicare Advantage or privately insured patients looks smaller here than it is.

Medicare patients62
Average patient age76

Dollar amounts are not shown. What Medicare pays a practice is gross billings, before staff, premises and tax and including the cost of any drugs it administers, so it is not what a clinician earns.

Payments from drug and device companies, 2025

Drug and device makers are required by federal law (the Physician Payments Sunshine Act) to report what they pay or give to clinicians, and CMS publishes the reports as Open Payments. This is the 2025 program year. A report is a record of a payment, not an allegation of anything, and many are small items such as meals. Only general payments are listed here; research payments and ownership or investment interests are reported separately by CMS and are not shown.

Food and Beverage $1,079 51 payments · a meal or drink at a meeting or visit, not a fee
Education $25 1 payment · educational material or training, not a fee

Each amount is the sum of what companies reported for that kind of payment in 2025, rounded to the dollar. Not all of it is income to the clinician: a meal is not a fee, a charitable contribution goes to a charity, and a royalty or an acquisition payment is not a salary.

Check a report, or dispute one, at the source in CMS’s own tool, Open Payments. Corrections go through CMS’s dispute process. This site removes a home address on request and asks for no proof, because that is privacy; it will not remove an accurate payment report on request, because that is a statutory public disclosure.

Other providers in Edison